Evaluation of palliative therapy, alone or in combination with toceranib phosphate, in dogs diagnosed with metastatic or recurrent beta-cell neoplasia.

Daniel Alonso-Miguel Paula García San JoséS González SanzI Clarés MoralMaría Dolores Pérez Alenza

Published in: New Zealand veterinary journal (2021)

The use of toceranib combined with palliative treatment in dogs with suspect metastatic or recurrent insulinomas increased survival time and was adequate tolerated.

Keyphrases

squamous cell carcinoma
small cell lung cancer
palliative care
advanced cancer
single cell
cell therapy
free survival